Documentos de Académico
Documentos de Profesional
Documentos de Cultura
Vithal Dhulkhed
Professor and Head ,Dept of Anesthesiology Krishna Institute of Medical Sciences (Deemed University) Karad, Maharashtra
informed clinical judgment to the anesthesiologist and the surgical team The patients current medical status Recommendations regarding the management and risk of cardiac(other) problems during the periop Period The patients clinical risk profile, to assist with treatment decisions that may affect short- or longterm cardiac (other)outcomes.
LEE A. FLEISHER, MD Robert D. Dripps Professor and Chair, Department of Anesthesiology and Critical Care, and Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA
Preoperative Assessment
Objectives
To deliver good quality care To establish doctor-patient rapport To establish a clinical picture of the patient To identify risk factors To draw up a management plan To optimise any concurrent medical conditions To minimise the occurrence of critical incidents in the perioperative period, drug interactions
% of pts
Perioperative Stress
With increasing surgical risk there is need to increase VO2
Postop mortality -
Surgical risk for cardiac events are related to the urgency, magnitude, type, and duration of the procedure, as well as the change in body core temperature, blood loss, and fluid shifts
Perioperative Stress.
Inability to increase CO is periop cardiac failure (PCF); focus on detection of forward CF.
.
It, is frequently occult in elderly;manifests as reduced exercise tolerance; Normally elderly patients adjust their level of activity when O2 demand>supply. The postop patient does not have this option
Anticipated prolonged or associated with large fluid shifts and/or blood loss
Perioperative Stress
low risk surgery -postopVO2 need <120 ml/min/m2
intermediate risk -VO2 120-150. high risk surgery >150 ml/M2. 40% over basal
after an operation OER is only 30%. Requiring 2.5-fold increase in postop CO Post op mortality is a function of preop cardiopulm failure and not MIsch
OER- Oxygen Extraction Ratio
10
Patient Factors
Medication
Patient Factors.
The low risk group < 60 yrs with no history of
cardiopulmonary disease or non-specific ECG changes, may proceed to surgery with little evaluation.
The high-risk group includes acute coronary
syndromes, decompensated cardiac failure, recent MI and supraventricular arrhythmias. -need further assessment and management.
12
Patient Factors.
Intermediate group >60 yrs ;stable angina, previous
assessment of myocardial function, detect M ischaemia, and be non-invasive,easily performed in elderly patients, reproducible and cost effective
13
physical examination are not cost effective, do not provide medicolegal protection, and in fact may harm the patient" (Roizen, 1987 ).
14
History Taking
Chart review
Present illness Family History: porphyria, malignant hyperpyraxia,
haemophilia, cholinesterase abnormalities and dystrophy myotonica . Disease of CVS & RS, exertional dyspnoea, paroxysmal nocturnal dyspnoea, orthopnoea, angina of effort, MI and COPD.
15
abnormalities , Thromboprophylaxis . Musculoskeletal Disease : Rheumatoid Arthritis . Renal Disease : Renal Failure , Patients on Dialysis . CNS Disease: Seizures , TIA , Stroke, Raise ICP. GI: Liver Disease , GERD , vomiting , diarrhea Endocrine Disease: Diabetes Mellitus
latex allergy and atopic patient HBV,HCV,HIV carriers have additional risk on staff. Special Precaution in infected patient:
17
18
Pregnancy
If its elective surgery then postpone it till delivery.
Many anaesthetic are teratogenic especially in early
stage.
They may induct spontaneous abortion.
19
Smoking; Alcohol
Smoking indicate: CVS problems , chronic bronchitis
or Lung CA. Causes tachycardia, increase peripheral resistance, decrease the availability of O2 by 25%, and increase RS complications by 6 folds. Stop 1 month prior ; or at least 6 hours before. Alcohol causes induction of liver enzyme, hepatic & cardiac damage, post-op delirium tremors due to withdrawal
20
Drug History
CVS medication: ACE Inhibitors, Diuretics,
B-
Blockers, Calcium channel blockers Antibiotics: Aminoglycosides,Sulphonamides. Anticoagulant: Warfarin, Aspirin, oral contraceptive, hormone replacement therapy Lithium and Insulin . Some drugs must be stopped before (contraceptive tablets .warfarin and MAOI )
21
Physical Examination
Full examination must be done even if its a minor surgery.
General: color, activity, weight, dehydrated, & type
of breathing. CVS: pulse volume, rate, and pressure, heart sounds, & BP. RS: Breathing sound, chest expansion, airway and trachea. Assessment of the ease of tracheal intubation.
22
Physical Examination
Teeth should be inspected for caries, caps and loose
teeth. Mouth opening Flexion of cervical spine & extension of Atlanto-occipital joint. CNS : cranial nerve examination , Eye Examination , Peripheral sensory & Motor Dysfunction
23
Anaesthetic history/assessment
Family history
Previous anaesthetics
PONV
allergy
malignant hyperpyrexia difficult airway
difficult IV access
Airway assessment
Best done by an anaesthetist Certain features of concern
small mouth poor dentition limited neck mobility scars/surgery/anatomical abnormalities obesity
Preoperative investigation
The request for pre-operative investigations should be
based on:
Factors apparent from the clinical assessment The likelihood of asymptomatic abnormalities The severity of the surgery contemplated Unnecessary lab testing is still common. A substantial
Barnard N A, Williams R W, Spencer E M. Preoperative patient assessment: a review of the literature and recommendations. Ann R Coll Surg Eng 1994; 76: 293-297
27
Chest X-ray Age >60 Significant RS disease CVS disease , If not done on last year, Rheu arthritis, thyroid goitre, diphtheria, malignancy
Full Blood Count Age >60 ,Clinical anaemia (?include for Hb age.<6mths,>40y or female:If Hb not obtained in 2mths,smoking >40 PY ) Haematological disease Renal disease ,Chemotherapy Procedures with bl loss > 15% Random Blood Sugar Age > 60 Symptoms of DM, DM, Liver dysfn, CNS dis, surgery involving interruption of bl supply to brain, Steroids, BMI>33 and no test in 2 mths
28
PFT COPD,Dyspnoea, Orthpnoea To test reversibility of bronchospasm, anticipated postop intubation, lung rsection
Coagulation Profile Haematological disease Liver disease ,SLE, Malnutrition Anticoagulation Intra-thoracic/Intra-cranial procedures Acute major trauma Preeclampsia, Vascular dis Renal disease
Renal Profile Age >60 , Morbid obesity Renal disease ,Liver disease DM, CVS, renal disease Procedures with bl loss > 15% Stable and unstable symptom swith no test for 2 mths Steroids, diuretics, drugs excreted by kidney
(These tests are recommended for administration of anaesthesia and are not intended to limit those required for issues specific to their surgical management)
Note: For healthy patients undergoing short, minimally invasive procedures, investigations may not be necessary.
29
Pregnancy Test
Patient is of child-bearing age and is sexually active and history suggests possible pregnancy, e.g., delayed menstruation, or patient is concerned about possible pregnancy or if possibility of pregnancy is uncertain
30
lost ) in dehydrated pt & low BP in shock pt. Recent ingestion of food. Failure to obtain informed consent. MI : wait 6 months
31
Dripps/ASA Classification
Class 1 2 Systemic Disturbance Healthy patient with no disease outside of the surgical process Mild-to-moderate systemic disease caused by the surgical condition or by other pathologic processes Mortality* <0.03% 0.2%
3
4 5 E
1.2%
8% 34% Increased
32
33
take my time. Grade II Specific street block limitations I have to stop for a while after one or two blocks. Grade III Dyspnea on mild exertion I have to stop and rest while going from kitchen to bathroom. Grade IV Dyspnea at rest,
34
35
Static Testing
o o o o
Dynamic Testing o Exercise ECG testing o Dobutamine stress echo o Dipyridimole stress echo o Dipyridimole thallium scintigraphy
o Cardiopulmonary exercise testing
Useful adjunct in evaluating CAD, not recommended for PAE functional assessment
36
37
Yes
Operating room
No
*Active cardiac conditions
Yes
No
Low Risk Surgery
Yes
No
Asymptomatic and good functional capacity >4MET
Yes
No or unknown
Acute or recent MI (7-30 d) Unstable coronary syndrome Decompensated CHF Significant Arrhythmias Severe Valvular Disease
Vascular Surgery
Vascular Surgery
Consider Testing
*Clinical risk factors = known ischemic heart disease, compensated or prior HF, diabetes, renal insufficiency, cerebrovascular disease
ECG Blood pressure; Expired air flow; O2 uptake from the air; CO2 output from the body; Arterial blood gases.
VO2 - volume of oxygen consumed ml/min (absolute) ml/kg/min (relative) METS - metabolic equivalents 1 MET = 3.5 ml/kg/min VCO2 - volume of carbon dioxide produced ml/min
40
disproportionate to rise in VO2 Indicates the level of exercise where body has reached maximal aerobic capacity
Termed the Anaerobic Threshold
41
Definition
VO2 max
(ml/min/kg)
AT
(ml/min/kg)
A B C D
42
Parameters Measured
43
restrictive and obstructive lung disease. Evaluates functional status before major surgery. AT >11 ml/ kg/min -no CV mortality,less hospital stay <11 ml/ kg/min postop CCU Low AT and peak VO2 --with poor outcome Major abdominal or thoracic surgery with significant ischaemia or pulm dysfunction are admitted to HDU postop for ECG and RS monitoring, even if mild CF
44
Perioperative Management
Revascularization
Beta blockers Statins
Alpha-2 agonists
Calcium channel blockers Aggressive pain control Avoidance of severe anemia Normothermia Vigilant monitoring
45
46
LV EF <50%; 3 = stable angina and 2-vessel disease with significant proximal LAD stenosis and either LV EF<50% or demonstrable ischaemia on non-invasive testing; 4 =high-risk unstable angina or non-STEMI; 5 =acute STEMI
47
Beta blockers required in recent past to control symptoms of angina or patients with symptomatic arrhythmias or hypertension
Patients at high cardiac risk owing to the finding of ischemia on preoperative testing who are undergoing vascular surgery Patients undergoing vascular surgery and with identified CAD Vascular surgery and multiple cardiac risk factors Moderate or high risk surgery and multiple cardiac risk factors
Key Point: if known or suspected CAD and undergoing moderate or high risk surgery, use a beta blocker!
Perioperative Statins
ACC/AHA 2007 Recommendations: Statins Class I: Patients currently taking statins Class IIa: Patients undergoing vascular surgery Class IIb: Patients with at least 1 clinical risk factor undergoing intermediate risk surgery
High risk patients (mitral valve, aortic valve + any risk factor*)
Bridge with UFH, starting when INR < 2
*Risk factors: AF, previous thromboembolism, LV dysfunction, hypercoagulable state, older generation valve, mechanical tricuspid valve, more than one mechanical valve
Pulmonary issues
PPC play important role in risk for patients
Contribute similar to cardiac complications in
BMI Dyspnea, COPD, OSA Inhaled tobacco use NYHA class >II, IHD, arrhythmia, pulmonary hypertension Nutrition status, lower serum albumin concentrations, DM, alk PO4 level of 125 U/L, increased complexity scores, and decreased functional status.
53
Incidence PPC %
OR 2.09;3.04 1.26
12.8% vs 16%),
22 to 44%
1.79 ;2.93 2.51;1.65 50% 1.83;2.21 from 2 to 19 ; 8 to 39 (27% vs 57%, respectively; 2.14
CPI = 91.0 - (0.65 * % predicted DLCO) - (0.53* % predicted FVC) - (0.34 * % predicted FEV1).
54
inspiratory and expiratory (MEP) pressures, and peak cough flow (PCF). For patients with FVC < 30%, preop use of noninvasive IPPV to be considered. Ineffective cough, defined as PCF < 270 L/min or MEP < 60 cm H2O, preop manual- and mechanically assisted cough considered.
55
or dyspnea. Head and neck, orthopedic, or lower abdominal surgery with unexplained dyspnea or pulmonary symptoms. Preop PFT need not lead to cancellation. Even severe COPD, can undergo surgery with an acceptable risk of pulm complications. Results should be interpreted in context of clinical situation
56
mouth wide open has a FEV 0.75 sec of at least 1,000 cc and a PFR of at least 130 liters per min.
Breath-holding test:
Rest five minutes. Take a full breath. Hold it
with mouth and nostrils closed. Note time in seconds. Breath-holding test of 10 to 15 seconds would indicate a vital capacity of 1500 cc. or less
57
turning around at each end, at normal pace, in 6 min. Median normal - 500600 m. Other measurements include SpO2 , HR ,dyspnoea scale and leg fatigue. >563 m - not routinely CPET; <427 m -further evaluation. uncertainty (427 but 563 m), Consider clinical risk factors and magnitude of surgery in the decision* less than 300 m -poor prognosis following aortic valve replacement >350 m for lung volume reduction surgery for management of significant COPD <200 m predict high 6-month mortality
Age, BMI Dyspnea, COPD, OSA Inhaled tobacco use IHD, arrhythmia, NYHA class II pul hypertension, Nutrition status, lower albumin, DM, alk PO4 level of 125 U/L, high complexity scores, and decreased functional status, pancuronium,surg site duration,GA
59
60
1 point each
None None < 34 (0-2) >35 (>3.5 g/dL) < 1.7
CTP A points = 5-6 , B = 7-9 , C = 10-15 Mortality rate(abdominal surgery.) : class A 10% class B : 30-31% class C- 76-82%
iMELD = MELD(3.8 ln bilirubin value) + (11.2 X ln INR) + (9.6 ln creatinine value), + (0.3 X age) - (0.7 X serum sodium [mEq/L]) + 100. ),
64
To summarise
Preoperative evaluation should be a team approach History and physical examination History-taking and the physical examination are still
the best means of preop screening, and Avoid unindicated lab tests Weigh the risk benefit ratio of surgery Provide optimal perioperative care by triage according to risk stratification Patients should have access to easily understood
information
65
67